Mycobacterium avium complex infection epidemiology and demographics

Not reportable. Population-based data available for Houston and Atlanta metropolitan areas suggest a rate of 1/100,000/year. Incidence is decreasing among HIV- infected patients as a result of new treatment modalities e.g., combination therapy with nucleoside reverse transcriptase inhibitors and protease inhibitors, as well as antimycobacterial prophylaxis. Incidence is decreasing because of changes in treatment for HIV-infected patients; however, antimicrobial resistance may be increasing.